Guangzhou Wondfo Biotech Co.,Ltd

Shenzhen Stock Exchange 300482.SZ

Guangzhou Wondfo Biotech Co.,Ltd Operating Income Margin for the year ending December 31, 2023: 19.86%

Guangzhou Wondfo Biotech Co.,Ltd Operating Income Margin is 19.86% for the year ending December 31, 2023, a -17.51% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.

Guangzhou Wondfo Biotech Co.,Ltd Operating Income Margin for the year ending December 31, 2022 was 24.08%, a 16.96% change year over year.
Guangzhou Wondfo Biotech Co.,Ltd Operating Income Margin for the year ending December 31, 2021 was 20.59%, a -21.82% change year over year.
Guangzhou Wondfo Biotech Co.,Ltd Operating Income Margin for the year ending December 31, 2020 was 26.33%, a 7.24% change year over year.
Guangzhou Wondfo Biotech Co.,Ltd Operating Income Margin for the year ending December 31, 2019 was 24.55%, a -1.67% change year over year.

Key data

Date	Operating Income Margin	EBT Margin	Net Income Margin	EBITDA Margin

Shenzhen Stock Exchange: 300482.SZ

Guangzhou Wondfo Biotech Co.,Ltd

CEO	Mr. Zhongxiong Peng
IPO Date	June 30, 2015
Location	China
Headquarters	No.8 Lizhishan Road
Employees	3,404
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

Guangzhou Wondfo Biotech Co.,Ltd, a biological company, engages in the research and development, production, and sale of point-of-care testing products, and rapid diagnosis and chronic disease management solutions. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious, fertility, and sexually transmitted diseases, as well as immunofluorescence devices to detect cardiovascular diseases, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and other diseases. It also provides blood gas, optical coagulation, and dry chemistry analyzers. The company was founded in 1992 and is headquartered in Guangzhou, China.

Key trends

Past 5 years